Structured nurse-led reassessment more than doubled clinically meaningful relief for hospitalised cancer patients, raising success rates from 38.0 percent to 80.0 percent in a before-and-after study. The study, published in the Indian Journal of Pain in August 2026, also found lower post-treatment scores on the Numerical Rating Scale, from 5.8 plus or minus 1.7 to 3.9 plus or minus 1.5.
The work was carried out by Dr Sapna Arun More and colleagues from the Department of Pharmacology at MGM Medical College in Indore. Over six months, a team evaluated 100 hospitalised adult patients in oncology wards at an Indian tertiary hospital. Nurses received interactive training, then carried out timed checks after analgesic treatment and escalated care to physicians when scores showed that relief was not enough.
Inadequately controlled pain remains widespread in hospitals despite established guidelines, the researchers note, largely because reassessment practices are inconsistent. Evidence on standardised nurse-led protocols in resource constrained settings has also been scarce. The new study set out to test whether a fixed workflow could close that gap in routine ward care.
What the pain reassessment protocol involved
The protocol gave nurses a set timetable for checking patients after they received analgesic medicines. Each check used the Numerical Rating Scale, a standard 0 to 10 scale on which patients rate the intensity of their pain. If a check showed that the score had not fallen enough, the nurse escalated the case to a physician so treatment could be adjusted.
Some patients need a different dose, an added medicine, or a change in timing. Without a second check, persistent pain can go unnoticed until the next routine round. With a fixed check, the ward team learns sooner that the first treatment has not worked, and can act while the patient is still under observation.
Training was part of the change. Nurses were taught the steps of the protocol and practised the timing of checks and escalation. The study measured changes in intensity, how promptly reassessment happened, rescue medication use and patient satisfaction, so the effect of the workflow could be judged on more than one measure.
How pain relief changed after the protocol
The headline result was the rise in clinically meaningful relief, defined as a fall of at least 2 points on the Numerical Rating Scale. That proportion rose from 38.0 percent at baseline to 80.0 percent after the intervention, an absolute difference of 42 percent, with a P value below 0.001. The mean pain score reduction was also larger after the intervention, at 3.0 plus or minus 1.2, compared with 1.3 plus or minus 0.9 at baseline.
Documented nursing reassessments rose from 46.0 percent to 94.0 percent, and timely evaluations rose from 30.0 percent to 88.0 percent, both with P values below 0.001. Rescue analgesic administration rose from 36.0 percent to 62.0 percent, with a P value of 0.009. The researchers read that rise as improved recognition of persistent symptoms, rather than overuse, because rescue medicines were given when checks showed that relief was incomplete.
Patient satisfaction rose as well. Combined satisfied and very satisfied responses reached 80.0 percent after the intervention, compared with 46.0 percent at baseline, with a P value of 0.002. The pattern across the measures points in the same direction: more checks, faster escalation, more rescue treatment where pain persisted, and higher satisfaction.
What the pain study does not yet prove
The study has limits that its authors acknowledge. It was a single centre evaluation with a before-and-after design, not a randomised trial. That design can show change over time, but it cannot rule out other influences, such as changes in staffing, case mix or ward routines during the six months. Observational bias is also possible, because staff knew the new protocol was being tested.
The authors therefore call for broader multicentre randomised studies with extended follow up before the approach is treated as settled evidence. A larger trial could test whether the same gains appear in hospitals with different staffing levels, different patient groups and different resources. It could also show whether gains last once the initial training period ends.
Even with those limits, the study authors conclude that clinicians may consider standardised bedside nurse reassessment protocols as a feasible, low cost strategy for routine oncology care. The approach does not depend on new drugs or new equipment. It depends on a timetable, a scale, a record of the check, and a clear route to a physician when the check shows that more help is needed. In a ward where those steps are followed, the study suggests, patients are more likely to get pain relief that they notice, and to notice it sooner.